Company Active LTD

Company profile

Canon Medical Research Europe, Limited

Canon Medical Research Europe, Limited is a UK company with status active founded in 2008 based in Scotland.

CRN
SC341779
Founded
2008
Age
18

Overview

Legal name
CANON MEDICAL RESEARCH EUROPE, LIMITED
Region
Scotland
Registered address
BONNINGTON BOND 2
ANDERSON PLACE
EDINBURGH
EH6 5NP
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

7 events
11 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

01 Jul
2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzUyOTgwMzM0NmFkaXF6a2N4

Published 01 Jul 2026 09:24

01 Jul
2026

Notification Of A Person With Significant Control

Persons-with-significant-control

PSC01 | Transaction MzUyOTgwMTc3MWFkaXF6a2N4

Published 01 Jul 2026 09:16

27 Apr
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

22 Apr
2008

Incorporated

Inception

Company registered at Companies House

Public funding

6 awards
First funded
2019
Funded years
2019, 2020, 2021, 2023, 2024
Age at first award
10 years

Projects

2024 Collaborative R&D

Glasgow Riverside Innovation District (GRID) Health Regulatory Science and Innovation Network

1 Mar 2024 to 31 Aug 2024

Awarded
£0
Total cost £0

Digital health is an area that has been growing for many years but importantly has been accelerated in recent years. This acceleration has been driven by: 1. the covid-19 pandemic boosting adoption of remote patient monitoring and telehealth, 2. development of artificial intelligence (AI) that enables analysis of large amounts of different types of data t...

2023 Investment Accelerator

Risk Stratification Tool for Colorectal Polyp Surveillance

1 Apr 2023 to 31 Mar 2025

Awarded
£326,147
Total cost £652,294

Bowel cancer screening is used to find bowel cancer and pre-cancerous lesions called polyps in patients without symptoms. The aim of screening is both to catch bowel cancers early -- making them easier to treat successfully -- and to prevent cancers by removing pre-cancerous polyps. Although timings vary across the UK, adults at a certain age are invited ...

2021 Collaborative R&D

Blackwood Neighbourhoods for Independent Living

1 Apr 2021 to 31 Mar 2024

Awarded
£0
Total cost £38,141

Blackwood and partners aim to co-design a neighbourhood or place-based innovation eco-system, with choice and control for residents as they age at its heart. Its role is to facilitate engagement and co-design, learn about healthy ageing in an agile way, position and adapt products and services in response. We create an **independent living movement** wher...

2020 Collaborative R&D

The Living Laboratory: driving economic growth in Glasgow through real world implementation of precision medicine

1 Oct 2020 to 30 Sep 2025

Awarded
£135,000
Total cost £759,625
2020 Collaborative R&D

Integrated Technologies for Improved Polyp Surveillance (INCISE)

1 Feb 2020 to 30 Apr 2023

Awarded
£296,434
Total cost £592,869

Public Project Summary

2019 Collaborative R&D

I-CAIRD: Industrial Centre for AI Research in Digital Diagnostics

1 Feb 2019 to 31 Mar 2023

Awarded
£0
Total cost £3,299,794

"iCAIRD will be a Scottish centre of excellence, centred at the Queen Elizabeth University Hospital in Glasgow but with sites across Scotland, to enable joined up academic and commercial technology development and research, locally and nationally. Making use of the capability of modern computers to process the large amounts of data gathered in healthcare ...

Product types

Collaborative R&D Investment Accelerator